Share of pregnant women with HIV that receive antiretroviral therapy in El Salvador

El Salvador: Share of pregnant women with HIV that receive antiretroviral therapy was 66.0% in 2024. ▲ Rising

Latest (2024)
66.0%
Change on year
down 25.0%
World rank
56th
of 84 countries
All-time high
90.0%
in 2021
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Share of pregnant women with HIV that receive antiretroviral therapy in El Salvador, 2000–2024

0204060801002000201220242000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 36 % of pregnant women living with HIV2003: 55 % of pregnant women living with HIV2004: 75 % of pregnant women living with HIV2005: 72 % of pregnant women living with HIV2006: 55 % of pregnant women living with HIV2007: 47 % of pregnant women living with HIV2008: 50 % of pregnant women living with HIV2009: 46 % of pregnant women living with HIV2010: 40 % of pregnant women living with HIV2011: 49 % of pregnant women living with HIV2012: 74 % of pregnant women living with HIV2013: 87 % of pregnant women living with HIV2014: 85 % of pregnant women living with HIV2015: 84 % of pregnant women living with HIV2016: 81 % of pregnant women living with HIV2017: 84 % of pregnant women living with HIV2018: 72 % of pregnant women living with HIV2019: 82 % of pregnant women living with HIV2020: 71 % of pregnant women living with HIV2021: 90 % of pregnant women living with HIV2022: 90 % of pregnant women living with HIV2023: 88 % of pregnant women living with HIV2024: 66 % of pregnant women living with HIV

Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of pregnant women living with HIV.

Analysis

The most recent figure for share of pregnant women with hiv that receive antiretroviral therapy in El Salvador is 66.0%, measured in 2024.

The figure is down 25.0% on the previous year and down 22.4% over ten years.

Over the whole period, share of pregnant women with hiv that receive antiretroviral therapy in El Salvador peaked at 90.0% in 2021 and was at its lowest, 0.0%, in 2000.

That places El Salvador 56th out of 84 countries with data for 2024, putting it in the middle of the range.

The long-run direction has been consistently rising across the 25 years of available data.

Share of pregnant women with HIV that receive antiretroviral therapy in El Salvador, year by year

Annual values for Share of pregnant women with HIV that receive antiretroviral therapy in El Salvador, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0% —
2001 0.0% —
2002 36.0% —
2003 55.0% +52.8%
2004 75.0% +36.4%
2005 72.0% -4.0%
2006 55.0% -23.6%
2007 47.0% -14.5%
2008 50.0% +6.4%
2009 46.0% -8.0%
2010 40.0% -13.0%
2011 49.0% +22.5%
2012 74.0% +51.0%
2013 87.0% +17.6%
2014 85.0% -2.3%
2015 84.0% -1.2%
2016 81.0% -3.6%
2017 84.0% +3.7%
2018 72.0% -14.3%
2019 82.0% +13.9%
2020 71.0% -13.4%
2021 90.0% +26.8%
2022 90.0% +0.0%
2023 88.0% -2.2%
2024 66.0% -25.0%

El Salvador compared with similar countries

  • El Salvador's 66.0% is below the median for upper middle income countries, which is 79.5%, 83% of the median. (22 countries reporting)
  • El Salvador's 66.0% is below the median for Latin America & Caribbean, which is 68.0%, 97% of the median. (15 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 43.6% 0.0% 75.0% 10
2010s 73.8% 40.0% 87.0% 10
2020s 81.0% 66.0% 90.0% 5

Countries ranked near El Salvador

  1. 54 Dominican Republic 68.0% compare
  2. 54 Laos 68.0% compare
  3. 56 Suriname 66.0% compare
  4. 58 Burundi 65.0% compare
  5. 58 Nepal 65.0% compare

See the full ranking of 84 places →

More gender data for El Salvador

All data for El Salvador →

Frequently asked questions

What is share of pregnant women with hiv that receive antiretroviral therapy in El Salvador?
Share of pregnant women with hiv that receive antiretroviral therapy in El Salvador was 66.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
What is the highest share of pregnant women with hiv that receive antiretroviral therapy recorded in El Salvador?
The highest recorded value was 90.0% in 2021.
What is the lowest share of pregnant women with hiv that receive antiretroviral therapy recorded in El Salvador?
The lowest recorded value was 0.0% in 2000.
How does El Salvador rank for share of pregnant women with hiv that receive antiretroviral therapy?
El Salvador ranks 56th out of 84 countries with data for 2024.
Is share of pregnant women with hiv that receive antiretroviral therapy rising or falling in El Salvador?
Over the last ten years it is down 22.4%. The long-run trend across the full record is rising.
Where does this El Salvador data come from?
The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of pregnant women with HIV that receive antiretroviral therapy in El Salvador. Statizoid, drawing on UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Retrieved 10 November 2026, from https://gender.statizoid.com/stat/art-coverage-for-pregnant-women/el-salvador/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/art-coverage-for-pregnant-women/el-salvador/">Share of pregnant women with HIV that receive antiretroviral therapy in El Salvador</a> — Statizoid

About this data

Indicator
Share of pregnant women with HIV that receive antiretroviral therapy
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, via World Bank (2026) – processed by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
84 places, 2,030 data points, 2000–2024
Last refreshed

Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.